C5 (UK) will be
holding its 2nd Forum on Pharma & Biotech Collaborations on May 14, 2013 in
Frankfurt, Germany. C5 faculty will
offer presentations on the following topics:
• Identifying the current deal
drivers and trends in deal-making: What it means for your next collaboration
agreement;
• How leading pharma & biotech choose
the right partner and deal structure;
• Executing robust agreements to underpin
fruitful collaborations and limit the potential for future disputes and
litigation;
• Successfully negotiating and drafting
collaborative research agreements with academic institutions;
• Effective alliance management: Avoiding
missteps and producing workable solutions for the inherent challenges of life
sciences collaborations;
• Putting the end first: Defining critical
termination rights from the outset;
• How much is it worth? Establishing the
deal valuation; and
• Overcoming
defects in IP that have the potential to derail collaborations and safeguarding
your rights during negotiations.
A complete brochure for this conference, including an agenda, list of speakers, detailed descriptions of conference sessions, and registration form can be downloaded here.
The registration
fee is €1399
(conference) or €995 (webinar). Those
registering by April 12, 2013 will receive a €200 discount. Those interested in registering for the conference can do so here, by
calling +44 20 7878 6888, by faxing a registration form to +44 20 7878 6885, or
by e-mailing [email protected].
Patent Docs is a media partner of C5's Pharma & Biotech Collaborations Forum.
Comments